2Philipsen HP, Reichart PA. Unicystic ameloblastoma. A review of 193 cases from the literature. Oral Oncol, 1998,34(3):317
3Ong'uti MN, Howells GL, Williams DM. An immunohistochemical study of keratin expression in ameloblastoma from a Kenyan population. Oral Dis, 1999,5(2):111
4Matsuo A, Ueno S. Immunohistochemical demonstration of keratin in ameloblastoma as an indication of tumour differentiation. J Oral Maxillofac Surg, 1991,49(3):282
二级参考文献24
1Shear M. J Oral Pathol Med, 1994, 23(1):1-11.
2Myoung H, Hong SP, Hong SD, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2001, 91 (33):328-333.
3Worrall SF. Br J Oral Maxillofac Surg, 1992, 30(1) :59-62.
4Jackson IT, Potparic Z, Farschlng M, et al. J Craniomaxillofac Surg, 1993, 21 (8) :319-325.
1Bames L, Eveson JW, Reichant P, et al. Pathology and genetics of head and neck tumors [ M ]. Lyons: IARC Press, 2005:284 - 327.
2Kubota Y, Yamashiro T, Oka S, et al. Relation between size of odontogenic jaw cysts and the pressure of fluid within [J]. Br J Oral Maxillofae Surg, 2004,42(5) :391 -395.
3Sabokbar A, Kudo O, Athanasou NA. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis[J]. J Orthop Res, 2003, 21 ( 1 ) : 73 - 80.
4Fan X, Rahnert JA, Murphy TC, et al. Response to mechanical strains in an immortalized pre-osteoblast cell is dependent on ERKI/2 [ J ]. J Cell Physiol, 2006,207 ( 2 ) :454 - 460.
5Dougall W, Chaisson M. Monoclonal antibody targeting RANKL as a therapy for cancer-induced bone diseases [ J ].Clin Calcium, 2006,16(4) :627 -635.
6Hofbauer LC, Neubauer A, Heufelder AE. Receptor activator of nuclear factor- kB ligand and osteoprotegerin : Potential implications for the pathogenesis and treatment of malignant bone diseases[J]. Cancer, 2001,92(3) : 460-470.
7Zhang YH, Heulsmann A, Tondravi MM, et al. Tumor necrosis factor-α stimulates RANKL-induced osteoclastogenisis via coupling of TNF type 1 receptor and RANK signaling pathways[J]. J Biol Chem, 2001,276( 1 ) :563 -568.
8Buzi F, Maccarinelli G, Guaragni B, et al. Serum osteoprotegerin and receptor activator of nuclear factor kB concentra- tions in normal children and in children with pubertal precocity, Turner's syndrome and rheumatoid arthritis[ J]. Clin Endocrinol, 2004,60( 1 ) :87 -91.
9Cuzzocrea S, Mazzon E, Dugo L, et al. Inducible nitric oxide synthase mediates bone loss in ovariectomized mice[ J]. Endocrinology ,2003,144 ( 3 ) : 1098 - 1107.
10Rahnert J, Fan X, Case N, et al. The role of nitric oxide in the mechanical repression of RANKL in bone stromal cells[J]. Bone, 2008,43(1):48-54.
